Post-doctoral Research Fellow 

Email： fazalmehmoodhu@szu.edu.cn; fazalmehmoodhu@hotmail.com

Website: https://scholar.google.com/citations?user=5Gspd7EAAAAJ&hl=en&oi=ao.

EDUCATION:

September 2018 – June 2021: PhD Microbiology, CAS-TWAS fellowship ((博士微生物学), 中国科学院武汉病毒研究所. Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. 

September 2014 – December 2016: Master Degree in Microbiology (硕士学位微生物, Department of Microbiology, Hazara University Mansehra, Pakistan.

March 2010 - June 2014: Bachelor Degree in Microbiology (本科微生物学), Department of Microbiology, Hazara University Mansehra, Pakistan.

WORKING EXPERIENCES:

August 2021-Present: Post-doctoral fellow (博士后): Shenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, China

September 2015- August 2017: Microbiologist and Infection Control officer (微生物学家和感染控制官员): Fatma Medical Laboratory (Private) Islamabad, Pakistan.

AWARDS:

I availed and was awarded the prestigious CAS-TWAS fellowship for Ph.D study. September 2018-June 2021.

RESEARCH INTERESTS:

Antimicrobial Resistance

Bacteriophages

Endolysin

Phage Therapy

Lysin Therapy

RESEARCH PROJECTS:

1) The role of bacteriophages endolysin as an alternative therapeutic agent against multi-drug resistant bacteria.

2)  A novel Acinetobacter baumannii bacteriophage endolysin LysAB54 with high antibacterial activity against multiple Gram-negative microbes.

3) The development of novel universal chimeric lysin against Gram-negative bacteria.

4) Co-evolution of bacteria and bacteriophage.

CONFERENCES:

1. International Workshop on Biosafety Laboratory Management and Techniques. Wuhan Institute of Virology, Chinese Academy of Sciences. December 17-18, 2020.  

2. National Workshop on Biosafety Laboratory Management and Techniques. Wuhan Institute of Virology, Chinese Academy of Sciences. November 25-28, 2020.

3. Honor Memorial Certificate awarded by Wuhan Institute of Virology, Chinese Academy of Sciences China, in honor of fighting the epidemic, testing the community for Coronavirus. January 20, 2021.  

4. Certificate awarded by Professor Hongping Wei, Principal Investigator of the Laboratory of Diagnostic Microbiology, Wuhan Institute of Virology, Chinese Academy of Sciences. In the reward, we did our best to fight off COVID-19. May 16, 2020, to May 24, 2020.

PUBLICATIONS:

1. Khan FM, Gondil VS, Li C, Jiang M, Li J, Yu J, Wei H and Yang H (2021) A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 with High Antibacterial Activity Against Multiple Gram-Negative Microbes. Front. Cell. Infect. Microbiol. 11:637313. https://doi.org/10.3389/fcimb.2021.637313.

2. Abdelrahman, F., Easwaran, M., Daramola, O. I., Ragab, S., Lynch, S., Oduselu, T. J., Khan, F. M., Ayobami, A., Adnan, F., Torrents, E., Sanmukh, S., & El-Shibiny, A. (2021). Phage-Encoded Endolysins. Antibiotics (Basel, Switzerland), 10(2), 124. https://doi.org/10.3390/antibiotics10020124.

3. Loh, B., Gondil, V. S., Manohar, P., Khan, F. M., Yang, H., & Leptihn, S. (2020). Encapsulation and Delivery of Therapeutic Phages. Applied and environmental microbiology, AEM.01979-20. Advance online publication. https://doi.org/10.1128/AEM.01979-20.

4. Khan, F. M., Ahmad, T., Gulistan, M., Chammam, W., Khan, M., & Hui, J. (2021). Epidemiology of coronaviruses, genetics, vaccines, and scenario of current pandemic of Coronavirus diseases 2019 (COVID-19): a fuzzy set approach. Human vaccines & immunotherapeutics, 1–7. Advance online publication. https://doi.org/10.1080/21645515.2020.1798697.

5. Ahmad, T., Khan, M., Khan, F. M., & Hui, J. (2020). Are we ready for the new fatal Coronavirus: scenario of Pakistan? Human vaccines & immunotherapeutics, 16(3), 736–738. https://doi.org/10.1080/21645515.2020.1724000.

6. Ahmad, T., Haroon, Dhama, K., Sharun, K., Khan, F. M., Ahmed, I., Tiwari, R., Musa, T. H., Khan, M., Bonilla-Aldana, D. K., J Rodriguez-Morales, A., & Hui, J. (2020). Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review. Turkish journal of biology = Turk biyoloji dergisi, 44(3), 132–145. https://doi.org/10.3906/biy-2005-63.

7. Gondil, V. S., Khan, F. M., Mehra, N., Kumar, D., Khullar, A., Sharma, T., ... & Yang, H. (2021). Clinical Potential of Bacteriophage and Endolysin Based Therapeutics: A Futuristic Approach. In Microbial Products for Health, Environment and Agriculture (pp. 39-58). Springer, Singapore.